$MDCX Secures $22 Million Non-Dilutive Financing — Is MDCX Preparing for Its Next Major Move?

Описание: Medicus Pharma (NASDAQ: MDCX) just announced a major $22 million non-dilutive financing deal, extending its projected cash runway beyond 24 months while supporting continued clinical development initiatives.

In this video, we break down:
• What the financing means for shareholders
• Why non-dilutive funding matters
• How this could accelerate the SkinJect skin cancer program
• The potential implications for biotech and penny stock investors
• Why some traders are closely watching MDCX heading into upcoming catalysts

Featuring commentary from Dr. Raza Bokhari discussing Medicus Pharma’s advancement of SkinJect toward a pivotal FDA trial for skin cancer.

Could this be one of the biotech stocks to watch in the coming weeks?

#MDCX #MedicusPharma #BiotechStocks #PennyStocks #StockMarket #Biotech #Nasdaq #StockTrading #Investing #CancerResearch #SkinCancer #SmallCapStocks #Bullish #FDA #HealthcareStocks

⚠️ DISCLAIMER: I am not a financial advisor. Trading involves substantial risk, and you may lose some or all of your invested capital. Always do your own research before making any investment decisions.